Joann J Kang1, David C Ritterband1, Sherif S Tolees1, John A Seedor2. 1. From the Departments of Ophthalmology, Montefiore Medical Center (Kang), Bronx, and New York Eye and Ear Infirmary of Mount Sinai (Ritterband, Seedor), New York, New York, USA; Magrabi Eye Hospital (Tolees), Jeddah, Saudi Arabia. 2. From the Departments of Ophthalmology, Montefiore Medical Center (Kang), Bronx, and New York Eye and Ear Infirmary of Mount Sinai (Ritterband, Seedor), New York, New York, USA; Magrabi Eye Hospital (Tolees), Jeddah, Saudi Arabia. Electronic address: jseedor@nyee.edu.
Abstract
PURPOSE: To evaluate the visual outcomes and complications of glued foldable intraocular lens (IOL) implantation in patients with a wide range of ocular pathologies and/or having combined surgical procedures. SETTING: New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. DESIGN: Retrospective case series. METHODS: A chart review was conducted of all glued foldable IOL procedures performed in eyes with absent or insufficient capsule support. Patients with a postoperative follow-up less than 3 months were excluded from analysis. Intraoperative and postoperative complications, the postoperative course, and visual and refractive outcomes were analyzed. RESULTS: Sixty-five eyes (64 patients) were evaluated over a mean follow-up of 9.1 months ± 6.2 (SD). Ocular comorbidities were present in 98.5% of eyes, and 95.4% had additional concurrent surgical procedures. There was a statistically significant improvement in corrected distance visual acuity (P = .046), with 89.2% of eyes achieving better or equal vision postoperatively. Intraoperative complications included ocular hemorrhage (10.8%), haptic deformation (10.8%), and haptic breakage (1.5%). Postoperative complications included elevated intraocular pressure (13.8%), optic capture (12.3%), persistent anterior chamber inflammation (6.2%), IOL tilt (4.6%), cystoid macular edema (3.1%), recurrent ocular hemorrhage (3.1%), and retinal detachment (1.5%). CONCLUSION: The glued foldable IOL technique resulted in favorable visual outcomes but with a moderate risk for IOL-related and other postoperative complications in eyes with complex ocular comorbidities having combined surgical procedures. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
PURPOSE: To evaluate the visual outcomes and complications of glued foldable intraocular lens (IOL) implantation in patients with a wide range of ocular pathologies and/or having combined surgical procedures. SETTING: New York Eye and Ear Infirmary of Mount Sinai, New York, New York, USA. DESIGN: Retrospective case series. METHODS: A chart review was conducted of all glued foldable IOL procedures performed in eyes with absent or insufficient capsule support. Patients with a postoperative follow-up less than 3 months were excluded from analysis. Intraoperative and postoperative complications, the postoperative course, and visual and refractive outcomes were analyzed. RESULTS: Sixty-five eyes (64 patients) were evaluated over a mean follow-up of 9.1 months ± 6.2 (SD). Ocular comorbidities were present in 98.5% of eyes, and 95.4% had additional concurrent surgical procedures. There was a statistically significant improvement in corrected distance visual acuity (P = .046), with 89.2% of eyes achieving better or equal vision postoperatively. Intraoperative complications included ocular hemorrhage (10.8%), haptic deformation (10.8%), and haptic breakage (1.5%). Postoperative complications included elevated intraocular pressure (13.8%), optic capture (12.3%), persistent anterior chamber inflammation (6.2%), IOL tilt (4.6%), cystoid macular edema (3.1%), recurrent ocular hemorrhage (3.1%), and retinal detachment (1.5%). CONCLUSION: The glued foldable IOL technique resulted in favorable visual outcomes but with a moderate risk for IOL-related and other postoperative complications in eyes with complex ocular comorbidities having combined surgical procedures. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.